Data / Form D filings / Slate Pharmaceuticals, Inc.
Slate Pharmaceuticals, Inc.: Form D filings
Slate Pharmaceuticals, Inc., a pharmaceuticals company in Durham, NC, filed 4 Form D notices with the SEC between 2009 and 2010. The latest, on September 27, 2010, reports $2 million sold of a $2 million offering to 40 investors.
Find out what Slate Pharmaceuticals, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 318 BLACKWELL STREET, SUITE 240, Durham, NC, 27701
- Phone
- (919) 682-8800
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2007
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1469231
The full lists. Form D filings in North Carolina: 984 rows, $49.20, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 27, 2010 | New notice | $2,000,000 | $1,990,000 | $10,000 | 40 | Sep 13, 2010 | sec.gov |
| Jan 29, 2010 | Amendment | $2,787,000 | $2,787,000 | $0 | 33 | Aug 7, 2009 | sec.gov |
| Nov 19, 2009 | Amendment | $2,787,000 | $2,616,950 | $170,050 | 33 | Aug 7, 2009 | sec.gov |
| Aug 18, 2009 | New notice | $2,787,000 | $970,630 | $1,816,370 | 13 | Aug 7, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Robert Stanley Whitehead | Executive Officer, Director | |
| Douglas Stanley Eckert | Director | |
| Michael Stanley Ford | Director | |
| Richard Robert DeSchutter | Director | |
| Anthony Robert Wild | Director | |
| William Robert Dahl | Director | |
| Trygve Robert Mikkelsen | Director |
Other pharmaceuticals companies in North Carolina that filed recently
- Dignify Therapeutics, LLC $800,000 · Sep 25, 2026
Every Form D from the week of Sep 27, 2010 · All recent filings in North Carolina · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Slate Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.